Skip to content
10-K

Annual Report

ALX ONCOLOGY HOLDINGS INC ALXO

0001193125-26-098454

← back to feed
Filed
Mar 9, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 2, 2026 131.61M sh
Shares Diluted FY 2025 · Dec 31, 2025 53.66M sh
Shares Diluted FY 2025 · Dec 31, 2024 52.17M sh
Shares Diluted FY 2025 · Dec 31, 2023 42.99M sh
Capex FY 2025 · Dec 31, 2025 $212K
Capex FY 2025 · Dec 31, 2024 $447K
Capex FY 2025 · Dec 31, 2023 $1.27M
Operating Cash Flow FY 2025 · Dec 31, 2025 −$84.14M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$121.91M
Operating Cash Flow FY 2025 · Dec 31, 2023 −$130.36M
Long Term Debt FY 2025 · Dec 31, 2025 $4.53M
Long Term Debt FY 2025 · Dec 31, 2024 $9.47M
Short Term Debt FY 2025 · Dec 31, 2025 $5.22M
Short Term Debt FY 2025 · Dec 31, 2024 $435K
Short Term Investments FY 2025 · Dec 31, 2025 $28.42M
Short Term Investments FY 2025 · Dec 31, 2024 $110.19M
Cash And Equivalents FY 2025 · Dec 31, 2025 $16.37M
Cash And Equivalents FY 2025 · Dec 31, 2024 $17.57M
Cash And Equivalents FY 2025 · Dec 31, 2023 $22.41M
Stockholders Equity FY 2025 · Dec 31, 2025 $25.98M
Stockholders Equity FY 2025 · Dec 31, 2024 $113.62M
Stockholders Equity FY 2025 · Dec 31, 2023 $189.71M
Stockholders Equity FY 2025 · Dec 31, 2022 $263.46M
Current Liabilities FY 2025 · Dec 31, 2025 $24.55M
Current Liabilities FY 2025 · Dec 31, 2024 $18.5M
Total Liabilities FY 2025 · Dec 31, 2025 $33.07M
Total Liabilities FY 2025 · Dec 31, 2024 $34.16M
Current Assets FY 2025 · Dec 31, 2025 $50.73M
Current Assets FY 2025 · Dec 31, 2024 $134.35M
Total Assets FY 2025 · Dec 31, 2025 $59.05M
Total Assets FY 2025 · Dec 31, 2024 $147.78M
Eps Diluted FY 2025 · Dec 31, 2025 −$1.90
Eps Diluted FY 2025 · Dec 31, 2024 −$2.58
Eps Diluted FY 2025 · Dec 31, 2023 −$3.74
Eps Basic FY 2025 · Dec 31, 2025 −$1.90
Eps Basic FY 2025 · Dec 31, 2024 −$2.58
Eps Basic FY 2025 · Dec 31, 2023 −$3.74
Sga Expense FY 2025 · Dec 31, 2025 $23.85M
Sga Expense FY 2025 · Dec 31, 2024 $26.09M
Sga Expense FY 2025 · Dec 31, 2023 $28.48M
Rd Expense FY 2025 · Dec 31, 2025 $77M
Rd Expense FY 2025 · Dec 31, 2024 $116.37M
Rd Expense FY 2025 · Dec 31, 2023 $141.8M
Net Income FY 2025 · Dec 31, 2025 −$101.7M
Net Income FY 2025 · Dec 31, 2024 −$134.85M
Net Income FY 2025 · Dec 31, 2023 −$160.81M
Operating Income FY 2025 · Dec 31, 2025 −$104.02M
Operating Income FY 2025 · Dec 31, 2024 −$142.47M
Operating Income FY 2025 · Dec 31, 2023 −$170.28M